0.41 USD
-0.15 (-26.96%)
0.3516 USD
-0.06 (-14.24%)
ChartMill assigns a Buy % Consensus number of 51% to CLSD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 61.2. This target is 14826.83% above the current price.
CLSD was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about CLSD.
In the last month the buy percentage fell by 23 points. So the trust of analysts is decreasing.
CLSD was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Needham | Reiterate | Hold -> Hold |
| 2025-07-18 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2025-07-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-07-17 | Needham | Downgrade | Buy -> Hold |
| 2025-05-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-15 | Needham | Maintains | Buy -> Buy |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-28 | Needham | Maintains | Buy -> Buy |
| 2025-03-06 | Needham | Reiterate | Buy -> Buy |
| 2025-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-10-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-10 | Needham | Maintains | Buy -> Buy |
| 2024-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-21 | Chardan Capital | Initiate | Buy |
| 2024-08-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-25 | Needham | Reiterate | Buy -> Buy |
| 2024-06-25 | Oppenheimer | Initiate | Outperform |
| 2024-05-13 | Needham | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
CLEARSIDE BIOMEDICAL INC / CLSD FAQ
Can you provide the average price target for CLEARSIDE BIOMEDICAL INC stock?
11 analysts have analysed CLSD and the average price target is 61.2 USD. This implies a price increase of 14826.83% is expected in the next year compared to the current price of 0.41.
Can you provide the consensus rating for CLEARSIDE BIOMEDICAL INC stock?
The consensus rating for CLEARSIDE BIOMEDICAL INC (CLSD) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.